BioCentury
ARTICLE | Financial News

Nohla adds $11M to series B

July 13, 2018 8:07 PM UTC

Off-the-shelf cell therapy company Nohla Therapeutics Inc. (Seattle, Wash.) raised an additional $11 million on June 11 in the second close of a series B financing, bringing the round’s total to $56 million. New investors University of Tokyo Edge Capital, Schroder Adveq and Premier Parnters joined the round. Nohla raised an initial $45 million in the round in May (see “Arch Leads Nohla’s $45M Series B”)...

BCIQ Company Profiles

Deverra Therapeutics Inc.